EW Edwards Lifesciences
NYSE · SEC CIK 1099800 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $27.68M 42 sales by 9 insiders
- Filings on record
- 445 since 2021-07-01, latest 2026-09-14 18:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| Zovighian Bernard J | CEO, Dir | — | $7.00M |
| Ullem Scott B. | CFO, CVP | — | $3.87M |
| Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| Bruls Annette | CVP, EMEACLA | — | $237.9K |
| STONE HEISZ LESLIE | Dir | — | $218.1K |
| Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| Davis Leslie C. | Dir | — | — |
Transactions 820
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-14 18:04 | 2026-09-11+ | EW | Markowitz Wayne | CVP, JAPAC | F - Tax | $85.29 | -923 | 19.4K | -5% | -$78.7K |
| 2026-09-14 18:04 | 2026-09-13 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | F - Tax | $84.37 | -253 | 14.6K | -2% | -$21.3K | |
| 2026-09-11 19:15 | 2026-09-11 | EW | Chopra Daveen | CVP, TMTT, Surgical, IHFM | F - Tax | $86.77 | -398 | 43.9K | -0.9% | -$34.5K | |
| DT | 2026-09-11 19:15 | 2026-09-11 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 40.7K | +2% | +$45.0K |
| DT | 2026-09-11 19:15 | 2026-09-11 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $87.51 | -619 | 40.0K | -2% | -$54.2K |
| 2026-08-31 17:47 | 2026-08-31 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | S - Sale | $91.06 | -544 | 14.9K | -4% | -$49.5K | |
| 2026-08-28 16:32 | 2026-08-28 | EW | Bruls Annette | CVP, EMEACLA | S - Sale | $89.98 | -2,644 | 18.0K | -13% | -$237.9K | |
| D | 2026-08-26 18:36 | 2026-08-26 | EW | Chopra Daveen | CVP, TMTT, Surgical, IHFM | M - OptEx | $72.68 | +31.8K | 76.1K | +72% | +$2.31M |
| DM | 2026-08-26 18:36 | 2026-08-26 | EW | Chopra Daveen | CVP, TMTT, Surgical, IHFM | S - Sale+OE | $91.02 | -31.8K | 44.3K | -42% | -$2.89M |
| 2026-08-26 18:00 | 2026-08-26 | EW | Markowitz Wayne | CVP, JAPAC | S - Sale | $91.47 | -1,240 | 20.3K | -6% | -$113.4K | |
| DT | 2026-08-11 17:07 | 2026-08-11 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 40.7K | +2% | +$45.0K |
| DT | 2026-08-11 17:07 | 2026-08-11 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $92.03 | -619 | 40.0K | -2% | -$57.0K |
| 2026-07-30 17:30 | 2026-07-30 | EW | Markowitz Wayne | CVP, JAPAC | S - Sale | $86.03 | -146.31 | 21.5K | -0.7% | -$12.6K | |
| D | 2026-07-28 19:40 | 2026-07-28 | EW | Markowitz Wayne | CVP, JAPAC | M - OptEx | $74.02 | +9,628 | 31.3K | +44% | +$712.7K |
| D | 2026-07-28 19:40 | 2026-07-28 | EW | Markowitz Wayne | CVP, JAPAC | S - Sale+OE | $85.06 | -9,628 | 21.7K | -31% | -$819.0K |
| 2026-07-27 18:59 | 2026-07-27 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -319.65 | 98.8K | -0.3% | $0 | |
| I | 2026-07-27 18:59 | 2026-07-27 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +319.65 | 11.8K | +3% | $0 |
| I | 2026-07-27 18:59 | 2026-07-27 | EW | Zovighian Bernard J | CEO, Dir | S - Sale | $83.93 | -2,921 | 8,916 | -25% | -$245.1K |
| 2026-07-13 16:09 | 2026-07-11 | EW | Bruls Annette | CVP, EMEACLA | F - Tax | $92.21 | -109 | 20.6K | -0.5% | -$10.1K | |
| DM | 2026-07-10 17:11 | 2026-07-09 | EW | Mistras Theodora | CFO, CVP | A - Grant | $0.00 | +99.9K | 99.9K | New | $0 |
| DT | 2026-07-10 17:04 | 2026-07-10 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 40.7K | +2% | +$45.0K |
| DT | 2026-07-10 17:04 | 2026-07-10 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $91.70 | -619 | 40.0K | -2% | -$56.8K |
| 2026-07-07 18:56 | 2026-07-07 | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $95.18 | -377 | 40.0K | -0.9% | -$35.9K | |
| DT | 2026-06-30 20:01 | 2026-06-30 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 41.0K | +2% | +$45.0K |
| DT | 2026-06-30 20:01 | 2026-06-30 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $91.40 | -619 | 40.4K | -2% | -$56.6K |
| TI | 2026-06-17 20:19 | 2026-06-17 | EW | Zovighian Bernard J | CEO, Dir | S - Sale | $87.92 | -523 | 11.5K | -4% | -$46.0K |
| 2026-05-29 16:44 | 2026-05-29 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | S - Sale | $86.08 | -567.53 | 15.3K | -4% | -$48.9K | |
| I | 2026-05-27 19:28 | 2026-05-27 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $86.42 | -23.1K | 98.6K | -19% | -$2.00M |
| 2026-05-22 16:35 | 2026-05-22 | EW | Chopra Daveen | CVP, TMTT, Surgical | S - Sale | $84.60 | -1,500 | 44.3K | -3% | -$126.9K | |
| DT | 2026-05-18 17:29 | 2026-05-18 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +620 | 41.0K | +2% | +$45.1K |
| DT | 2026-05-18 17:29 | 2026-05-18 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $81.14 | -620 | 40.4K | -2% | -$50.3K |
| 2026-05-18 17:28 | 2026-05-15 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $82.07 | -9,968 | 22.8K | -30% | -$818.1K | |
| I | 2026-05-18 17:28 | 2026-05-15 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $81.82 | -8,000 | 31.0K | -21% | -$654.6K |
| DT | 2026-05-12 16:55 | 2026-05-11 | EW | Zovighian Bernard J | CEO, Dir | M - OptEx | $0.00 | +47.2K | 157.5K | +43% | $0 |
| DT | 2026-05-12 16:55 | 2026-05-11 | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $79.96 | -26.2K | 125.8K | -17% | -$2.09M |
| DT | 2026-05-12 16:55 | 2026-05-12 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -26.6K | 99.2K | -21% | $0 |
| DTI | 2026-05-12 16:55 | 2026-05-12 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +26.6K | 48.4K | +122% | $0 |
| DMTI | 2026-05-12 16:55 | 2026-05-12 | EW | Zovighian Bernard J | CEO, Dir | S - Sale+OE | $77.93 | -36.4K | 12.0K | -75% | -$2.83M |
| D | 2026-05-12 16:52 | 2026-05-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | +13.5K | 40.2K | +50% | $0 |
| D | 2026-05-12 16:52 | 2026-05-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | F - Tax | $79.96 | -7,469 | 32.8K | -19% | -$597.2K |
| D | 2026-05-12 16:50 | 2026-05-11 | EW | Chopra Daveen | CVP, TMTT, Surgical | M - OptEx | $0.00 | +13.6K | 53.4K | +34% | $0 |
| D | 2026-05-12 16:50 | 2026-05-11 | EW | Chopra Daveen | CVP, TMTT, Surgical | F - Tax | $79.96 | -7,538 | 45.8K | -14% | -$602.7K |
| D | 2026-05-11 21:59 | 2026-05-11 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +19.8K | 57.7K | +52% | $0 |
| D | 2026-05-11 21:59 | 2026-05-11 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $79.96 | -11.0K | 46.7K | -19% | -$879.9K |
| D | 2026-05-11 21:33 | 2026-05-07 | EW | Markowitz Wayne | CVP, JAPAC | A - Grant | $0.00 | +5,200 | 22.8K | +30% | $0 |
| DM | 2026-05-11 21:33 | 2026-05-07+ | EW | Markowitz Wayne | CVP, JAPAC | F - Tax | $83.00 | -490 | 22.3K | -2% | -$40.7K |
| D | 2026-05-11 21:33 | 2026-05-11 | EW | Markowitz Wayne | CVP, JAPAC | S - Sale | $79.73 | -593 | 21.7K | -3% | -$47.3K |
| D | 2026-05-11 21:32 | 2026-05-07 | EW | Zovighian Bernard J | CEO, Dir | A - Grant | $0.00 | +43.8K | 124.1K | +55% | $0 |
| DM | 2026-05-11 21:32 | 2026-05-07+ | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $82.95 | -9,551 | 110.3K | -8% | -$792.3K |
| DM | 2026-05-11 21:32 | 2026-05-08+ | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -9,711 | 104.8K | -8% | $0 |
| DMI | 2026-05-11 21:32 | 2026-05-08+ | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +9,711 | 21.8K | +81% | $0 |
| 2026-05-11 21:32 | 2026-05-11 | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $79.96 | -362 | 40.4K | -0.9% | -$28.9K | |
| 2026-05-08 21:18 | 2026-05-08 | EW | VALERIANI NICHOLAS J | Dir | A - Grant | $0.00 | +5,127 | 84.4K | +6% | $0 | |
| 2026-05-08 21:18 | 2026-05-08 | EW | Sequeira Ramona | Dir | A - Grant | $0.00 | +3,251 | 6,779 | +92% | $0 | |
| M | 2026-05-08 21:18 | 2026-05-08 | EW | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +4,315 | 8,997 | +92% | $0 |
| 2026-05-08 21:17 | 2026-05-08 | EW | LAVIOLETTE PAUL A | Dir | A - Grant | $0.00 | +3,251 | 17.6K | +23% | $0 | |
| 2026-05-08 21:17 | 2026-05-08 | EW | STONE HEISZ LESLIE | Dir | A - Grant | $0.00 | +3,251 | 34.2K | +11% | $0 | |
| M | 2026-05-08 21:17 | 2026-05-08 | EW | GALLAHUE KIERAN | Dir | A - Grant | $0.00 | +4,315 | 4,315 | New | $0 |
| 2026-05-08 21:17 | 2026-05-08 | EW | Feinberg David T | Dir | A - Grant | $0.00 | +3,251 | 9,087 | +56% | $0 | |
| D | 2026-05-08 21:17 | 2026-05-07 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | A - Grant | $0.00 | +7,850 | 28.6K | +38% | $0 |
| DM | 2026-05-08 21:17 | 2026-05-07+ | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | F - Tax | $82.96 | -1,869 | 26.8K | -7% | -$155.0K |
| M | 2026-05-08 21:16 | 2026-05-07+ | EW | Ullem Scott B. | CFO, CVP | F - Tax | $82.96 | -3,034 | 37.9K | -7% | -$251.7K |
| 2026-05-08 21:16 | 2026-05-08 | EW | Davis Leslie C. | Dir | A - Grant | $0.00 | +3,251 | 9,834 | +49% | $0 | |
| D | 2026-05-08 21:16 | 2026-05-07 | EW | Lippis Daniel J. | CVP, TAVR | A - Grant | $0.00 | +7,850 | 41.5K | +23% | $0 |
| DM | 2026-05-08 21:16 | 2026-05-07+ | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $82.94 | -759 | 40.8K | -2% | -$63.0K |
| DM | 2026-05-08 21:16 | 2026-05-07 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | A - Grant | $0.00 | +7,005 | 16.2K | +76% | $0 |
| D | 2026-05-08 21:16 | 2026-05-08 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | F - Tax | $82.76 | -289 | 15.9K | -2% | -$23.9K |
| D | 2026-05-08 21:16 | 2026-05-07 | EW | Chopra Daveen | CVP, TMTT, Surgical | A - Grant | $0.00 | +9,675 | 41.6K | +30% | $0 |
| DM | 2026-05-08 21:16 | 2026-05-07+ | EW | Chopra Daveen | CVP, TMTT, Surgical | F - Tax | $82.92 | -1,815 | 39.8K | -4% | -$150.5K |
| D | 2026-05-08 21:15 | 2026-05-07 | EW | Bruls Annette | CVP, EMEACLA | A - Grant | $0.00 | +6,650 | 20.8K | +47% | $0 |
| D | 2026-05-08 21:15 | 2026-05-08 | EW | Bruls Annette | CVP, EMEACLA | F - Tax | $82.76 | -84 | 20.7K | -0.4% | -$6,952 |
| DM | 2026-05-05 19:08 | 2026-05-03+ | EW | Ullem Scott B. | CFO, CVP | F - Tax | $82.97 | -11.8K | 40.9K | -22% | -$974.9K |
| D | 2026-05-05 19:08 | 2026-05-05 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.1K | +33% | +$770.3K |
| 2026-05-05 19:05 | 2026-05-03 | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $83.98 | -515 | 80.8K | -0.6% | -$43.2K | |
| 2026-05-05 19:05 | 2026-05-05 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -523 | 80.3K | -0.6% | $0 | |
| I | 2026-05-05 19:05 | 2026-05-05 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +523 | 12.0K | +5% | $0 |
| DMT | 2026-05-04 19:30 | 2026-05-01+ | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +2,038 | 34.7K | +6% | +$120.8K |
| DMT | 2026-05-04 19:30 | 2026-05-01+ | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $83.49 | -2,038 | 33.7K | -6% | -$170.2K |
| DT | 2026-05-04 19:30 | 2026-05-03 | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $83.98 | -252 | 33.7K | -0.7% | -$21.2K |
| 2026-05-04 19:29 | 2026-05-03 | EW | Chopra Daveen | CVP, TMTT, Surgical | F - Tax | $83.98 | -282 | 31.9K | -0.9% | -$23.7K | |
| 2026-05-04 19:29 | 2026-05-03 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | F - Tax | $83.98 | -469 | 20.8K | -2% | -$39.4K | |
| DT | 2026-04-09 19:34 | 2026-04-09 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.7K | +33% | +$770.3K |
| DMT | 2026-04-09 19:34 | 2026-04-09 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $80.04 | -13.0K | 39.7K | -25% | -$1.04M |
| DT | 2026-04-06 20:42 | 2026-04-06 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +1,019 | 35.0K | +3% | +$60.4K |
| DT | 2026-04-06 20:42 | 2026-04-06 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $80.98 | -1,019 | 33.9K | -3% | -$82.5K |
| DT | 2026-04-02 17:13 | 2026-04-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $59.26 | +22.7K | 43.9K | +107% | +$1.34M |
| DMT | 2026-04-02 17:13 | 2026-04-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $80.16 | -22.7K | 21.3K | -52% | -$1.82M |
| D | 2026-03-11 | 2026-03-11 | EW | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +1,019 | 35.0K | +3% | +$60.4K |
| D | 2026-03-11 | 2026-03-11 | EW | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $85.38 | -1,019 | 33.9K | -3% | -$87.0K |
| DM | 2026-03-11 | 2026-03-11 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.92 | -13.0K | 47.6K | -21% | -$1.10M |
| D | 2026-03-11 | 2026-03-11 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.7K | +33% | +$770.4K |
| D | 2026-03-02 | 2026-03-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $85.93 | -11.3K | 21.3K | -35% | -$974.4K |
| D | 2026-03-02 | 2026-03-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $59.26 | +11.3K | 32.6K | +53% | +$672.0K |
| 2026-02-26 | 2026-02-25 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $83.84 | -24.0K | 21.3K | -53% | -$2.01M | |
| 2026-02-23 | 2026-02-22 | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $79.78 | -432 | 33.9K | -1% | -$34.5K | |
| 2026-02-23 | 2026-02-22 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | F - Tax | $79.78 | -176 | 9,089 | -2% | -$14.0K | |
| 2026-02-17 | 2026-02-16 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $75.87 | -199 | 39.7K | -0.5% | -$15.1K | |
| M | 2026-02-17 | 2026-02-16+ | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $75.87 | -456 | 34.6K | -1% | -$34.6K |
| 2026-02-17 | 2026-02-12 | EW | Lippis Daniel J. | CVP, TAVR | A - Grant | $0.00 | +12.8K | 34.8K | +58% | $0 | |
| DM | 2026-02-13 | 2026-02-12 | EW | Zovighian Bernard J | CEO, Dir | S - Sale+OE | $76.67 | -22.4K | 103.8K | -18% | -$1.72M |
Purchase Sale Sale after option exercise All abbreviations